Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions

Journal of Virology

Volumn 72, Issue 10, 1998, Pages 8220-8229

  Balmelli, Carole ^a   Roden, Richard ^b   Potts, Alexandra ^a   Schiller, John ^b   De Grandi, Pierre ^a   Nardelli Haefliger, Denise ^a,c  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b NATIONAL CANCER INSTITUTE   (United States)

^c c/o Institut de Microbiologie ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS VACCINE; WART VIRUS VACCINE;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; DIGESTIVE TRACT SECRETION; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION; INTRANASAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VAGINA SECRETION; VIRUS PARTICLE; WART VIRUS;

EID: 0031668082     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.10.8220-8229.1998     Document Type: Article

References (66)

1. Allardyce, R. A. 1984. Effect of ingested sperm on fecundity in the rat. J. Exp. Med. 159:1548-1553.
2. Bachmann, M. F., and R. M. Zinkernagel. 1996. The influence of virus structure on antibody responses and virus serotype formation. Immunol. Today 17:553-558.
3. Berg, E. L., M. K. Robinson, R. A. Warnock, and E. C. Butcher. 1991. The human peripheral lymph node vascular addressin is a ligand for LECAM-1, the peripheral lymph node homing receptor. J. Cell Biol. 114:343-349.
4. Berlin, C., E. L. Berg, M. J. Briskin, D. P. Andrew, P. J. Kilshaw, B. Holzmann, I. L. Weissman, A. Hamann, and E. C. Butcher. 1993. Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74:185-195.
5. Bessen, D., and V. A. Fischetti. 1988. Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A. J. Exp. Med. 167: 1945-1950.
6. Bienenstock, J., M. McDermott, D. Befus, and M. O'Neill. 1978. A common mucosal immunologic system involving the bronchus, breast and bowel. Adv. Exp. Med. Biol. 107:53-59.
7. Bosch, F. X., M. M. Manos, N. Munoz, M. Sherman, A. M. Jansen, J. Peto, M. H. Schiffman, V. Moreno, R. Kurman, and K. V. Shah. 1995. Prevaleńce of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J. Natl. Cancer Inst. 87:796-802.
8. Bouvet, J. P., L. Belec, R. Pires, and J. Pillot. 1994. Immunoglobulin G antibodies in human vaginal secretions after parenteral vaccination. Infect. Imm. 62:3957-3961.
9. Brandtzaeg, P. 1989. Overview of the mucosal immune system. Curr. Top. Microbiol. Immunol. 146:13-25.
10. Breitburd, F., R. Kirnabauer, N. Hubbert, B. Nonnenmacher, C. Trin-Dinh-Desmarquet, G. Orth, J. T. Schiller, and D. R. Lowy. 1995 Immunization with wiruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J. Virol. 69:3959-3963.
11. Briskin, M., D. Winsorhines, A. Shyjan, N. Cochran, S. Bloom, J. Wilson, L. M. Mcevoy, E. C. Butcher, N. Kassam, C. R. Mackay, W. Newman, and D. J. Ringler. 1997. Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am. J. Pathol. 151:97-110.
12. Bryan, J. T., K. U. Jansen, R. S. Lowe, K. H. Fife, T. McClowry, D. Glass, and D. R. Brown. 1997. Human papillomavirus type 11 neutralization in the athymic mouse xenograft system - correlation with virus-like particle IgG concentration. J. Med. Virol. 53:185-188.
13. Childers, N. K., M. G. Bruce, and J. R. McGhee. 1989. Molecular mechanisms of immunoglobulin A defense. Annu. Rev. Microbiol. 43:503-536.
14. Dehaan, A., K. B. Renegar, P. J. Small, and J. Wilschut. 1995. Induction of a secretory IgA response in the murine female urogenital tract by immunization of the lungs with liposome-supplemented viral subunit antigen. Vaccine 13:613-616.
15. Dehaan, A., J. F. Tomee, J. P. Huchshorn, and J. Wilschut. 1995. Liposomes as an immunoadjuvant system for stimulation of mucosal and systemic antibody responses against inactivated measles virus administered intranasally to mice. Vaccine 13:1320-1324.
16. Di Tomaso, A., G. Saletti, M. Pizza, R. Rappuoli, G. Dougan, S. Abrignani, G, Douce, and M. M. De. 1996. Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant. Infect. Imm. 64:974-979.
17. Drew, M. D., C. A. Estrada, B. J. Underdown, and M. R. McDermott. 1992. Vaccination by cholera toxin conjugated to a herpes simplex virus type 2 glycoprotein D peptide. J. Gen. Virol. 73:2357-2366.
18. Eldridge, J. H., J. K. Staas, J. A. Meulbroek, J. R. McGhee, T. R. Tice, and R. M. Gilley. 1191. Biodegradable microspheres as a vaccine delivery system. Mol. Immunol. 28:287-294.
19. Gallichan, W. S., and K. L. Rosenthal. 1996. Effects of the estrous cycle on local humoral immune responses and protection of intranasally immunized female mice against herpes simplex virus type 2 infection in the genital tract. Virology 224:487-497.
20. Gallichan, W. S., and K. L. Rosenthal. 1995. Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus. Vaccine 13:1589-195.
21. Hagensee, M. E., J. J. Carter, G. C. Wipf, and D. A. Galloway. 1995. Immunization of mice with HPV vaccinia virus recombinants generates serum IgG, IgM, and mucosal IgA antibodies. Virology 206:174-182.
22. Hagensee, M. E., N. Yaegashi, and D. A. Galloway. 1993. Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J. Virol. 67:315-322.
23. Hamann, A., D. P. Andrew, W. D. Jablonski, B. Holzmann, and E. C. Butcher. 1994. Role of alpha 4-integrins in lymphocyte homing to mucosal tissues in vivo. J. Immunol. 152:3282-3293.
24. Hofmann, K. J., J. C. Cook, J. G. Joyce, D. R. Brown, L. D. Schultz, H. A. George, M. Rosolowsky, K. H. Fife, and K. U. Jansen. 1995. Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae. Virology 209:506-518.
25. Hopkins, S., J.-P. Kraehenbuhel, F. Schödel, A. Potts, D. Peterson, P. De Grandi, and D. Nardelli-Haefliger. 1995. A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization. Infect. Imm. 63:3279-3286.
26. Jackson, R. J., K. Fujihashi, A. J. Xu, H. Kiyono, C. O. Elson, and J. R. McGhee. 1993. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxin by use of cholera toxin as an adjuvant. Infect. Immun. 61:4272-4279.
27. Johansson, E. L., C. Rask, M. Fredriksson, K. Eriksson, C. Czerkinsky, and J. Holmgren. 1998. Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin b subunit or conjugates. Infect. Immun. 66:514-520.
28. Kirnbauer, R., F. Booy, N. Cheng, D. R. Lowy, and J. T. Schiller. 1992. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc. Natl. Aead. Sci. USA 89:12180-12184.
29. Kirnbauer, R., L. M. Chandrachud, B. W. Oneil, K. R. Wagner, G. J. Grindlay, A. Armstrong, G. M. Mcgarvie, J. T. Schiller, D. R. Lowy, and M. S. Campo. 1996. Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization. Virology 219:37-44.
30. Kirnbauer, R., J. Taub, H. Greenstone, R. Roden, M. Dürst, L. Gissmann, D. R. Lowy, and J. T. Schiller. 1993. Efficient sell-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J. Virol. 67:6929-6936.
31. Kutteh, W. H., R. E. Blackwell, H. Gore, C. C. Kutteh, B. R. Carr, and J. Mestecky. 1990. Secretory immune system of the female reproductive tract. II. Local immune system in normal and infected fallopian tube. Fertil. Steril. 54:51-55.
32. Lehner, T., C. Panagiotidi, L. A. Bergmeier, T. Ping, R. Brookes, and A. S. E. 1992. A comparison of the immune response following oral, vaginal, or rectal route of immunization with SIV antigens in nonhuman primates. Vaccine Res. 1:319-330.
33. Lowe, R. S., D. R. Brown, J. T. Bryan, J. C. Cook, H. A. George, K. J. Hofmann, W. M. Hurni, J. G. Joyce, E. D. Lehman, H. Z. Markus, M. P. Neeper, L. D. Schultz, A. R. Shaw, and K. U. Jansen. 1997. Human papillomavirus type 11 (hpv-11) neutralizing antibodies in the serum and genital mucosal secretions of african green monkeys immunized with hpv-11 virus-like particles expressed in yeast. J. Infect. Dis. 176:1141-1145.
34. Lowy, D. R., R. Kirnbauer, and J. T. Schiller. 1994. Genital human papillomavirus infection. Proc. Natl. Acad. Sci. USA 91:2436-2440.
35. Magnusson, K. E., and I. Stjernstrom. 1982. Mucosal harrier mechanisms. Interplay between secretory IgA (SIgA), IgG and mucins on the surface properties and association of salmonellae with intestine and granulocytes. Immunology 45:239-248.
36. Marinaro, M., H. F. Staats, T. Hiroi, R. J. Jackson, M. Coste, P. N. Boyaka, N. Okahashi, M. Yamamoto, H. Kiyono, H. Bluethmann, et al. 1995. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J. Immunol. 155:4621-4629.
37. Marx, P. A., R. W. Compans, A. Gettie, J. K. Staas, R. M. Gilley, M. J. Mulligan, G. V. Yamschikov, D. Chen, and J. H. Eldridge. 1993. Protection against vaginal SIV transmission with microencapsulated vaccine. Science 260:1323-1237.
38. Marx, P. A., R. W. Compans, A. Gettie, J. K. Stass, R. M. Gilley, M. J. Mulligan, G. V. Yamshchikov, D. Chen, and J. H. Eldridge. 1993. Protection against vaginal SIV transmission with microencapsulated vaccine. Science 260:1323-1327.
39. McDermott, M., and J. Bienenstock. 1979. Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues. J. Immunol. 122:1892-1898.
40. McDermott, M. R., D. A. Clark, and J. Bienenstock. 1980. Evidence for a common mucosal immunologic system. II. Influence of the estrous cycle on B immunoblast migration into genital and intestinal tissues. J. Immunol. 124:2536-2539.
41. Mills, J. T., K. J. Van, P. F. Wright, and R. M. Chanock. 1971. Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness. J. Immunol. 107:123-130.
42. Mogens, D., and M. W. Russell. 1994. Function of mucosal immunoglobulins, p. 127-137. In P. L. Gra et al. (ed.), Handbook of mucosal immunology. Academic Press, Inc., San Diego, Calif.
43. Nardellihaefliger, D., R. Roden, J. Benyacoub, R. Sahli, J. P. Kraehenbuhl, J. T. Schiller, P. Lachat, A. Potts, and P. Degrandi. 1997. Human papillomavirus type 16 virus-like particles expressed in attenuated salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice. Infect. Immun. 65:3328-3336.
44. Ogra, P. L., and D. T. Karzon. 1969. Poliovirus antibody response in serum and nasal secretions following intranasal inoculation with inactivated poliovaccine. J. Immunol. 102:15-23.
45. Ogra, P. L., and S. S. Ogra. 1973. Local antibody response to poliovaccine in the human female genital tract. J. Immunol. 110:1307-1311.
46. O'Neal, C. M., S. E. Crawford, M. K. Estes, and M. E. Conner. 1997. Rotavirus virus-like particles administered mucosally induce protective immunity. J. Virol. 71:8707-8717.
47. Pal, S., E. M. Peterson, and L. de la Maza. 1996. Intranasal immunization induces long-term protection in mice against a Chlamydia trachomatis genital challenge. Infect. Immun. 64:5341-5348.
48. Parr, M. B., and E. L. Parr. 1985. Immunohistochemical localization of immunoglobulins A, G and M in the mouse female genital tract. J. Reprod. Fertil. 74:361-370.
49. Quidingjarbrink, M., I. Nordstrom, G. Granstrom, A. Kilander, M. Jertborn, E. C. Butcher, A. I. Lazarovits, J. Holmgren, and C. Czerkinsky. 1997. Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations - a molecular basis for the compartmentalization of effector b cell responses. J. Clin. Investig. 99:1281-1286.
50. Roden, R. B. S., H. L. Greenstone, R. Kirnabauer, J. P. Booy, J. Jessie, D. R. Lowy, and J. T. Schiller. 1996. In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype. J. Virol. 70: 5875-5883.
51. Rose, R. C., R. C. Reiehmann, and W. Bonnez. 1994. Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera. J. Gen. Virol. 75:2075-2079.
52. Russell, M. W., Z. Moldoveanu, P. L. White, G. J. Sibert, J. Mestecky, and S. M. Michalek. 1996. Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the cholera toxin b subunit. Infect. Immun. 64:1272-1283.
53. Sasagawa, T., P. Pushko, G. Steers, S. E. Gshmeissner, M. A. N. Hajibagheri, J. Finch, L. Crawford, and M. Tommasino. 1995. Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe. Virology 206:126-135.
54. Sminia, T., G. J. van der Brugge-Gamelkoorn, and S. H. Jeurissen. 1989. Structure and function of bronchus-associated lymphoid tissue (BALT). Crit. Rev. Immunol. 9:119-145.
55. Staats, H. F., W. G. Nichols, and T. J. Palker. 1996. Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A). J. Immunol. 157:462-472.
56. Suzich, J. A., S. J. Ghim, F. J. Palmerhill, W. I. White, J. K. Tamura, J. A. Bell, J. A. Newsome, A. B. Jenson, and R. Schlegel. 1995. Systemic immunization with papillomavirus 11 protein completely prevents the development of viral mucosal papillomas. Proc. Natl. Acad. Sci. USA 92:11553-11557.
57. Svennerholm, A. M., L. A. Hanson, J. Holmgren, B. S. Lindblad, B. Nilsson, and F. Quereshi. 1980. Different secretory immunoglobulin A antibody responses to cholera vaccination in Swedish and Pakistani women. Infect. Immun. 30:427-430.
58. Thapar, M. A., E. L. Parr, and M. B. Parr. 1990. Secretory immune responses in mouse vaginal fluid after pelvic, parenteral or vaginal immunization. Immunology 70:121-125.
59. Usala, S. J., F. O. Usala, R. Haciski, J. A. Holt, and G. F. Schumacher. 1989. IgG and IgA content of vaginal fluid during the menstrual cycle. J. Reprod. Med. 34:292-294.
60. Waldo, F. B., A. W. van den Wall Bake, J. Mestecky, and S. Husby. 1994. Suppression of the immune response by nasal immunization. Clin. lmmunol. Immunopathol. 72:30-34.
61. Ward, M. E. 1992. Vaccination against chlamydial genital tract infection: a key problem of mucosal immunology, p. 409-425. In P. D. Gufio and P. Johnson (ed.), Local immunity in reproductive tract tissues. Oxford University Press, New Delhi, India.
62. Wira, C., J. Richardson, and R. Pabhala. 1994. Endocrine regulation of mucosal immunity: effect of sex hormones and cytokine on the afferent and efferent arms of the immune system in the female reproductive tract. Academic press, Inc., San Diego, Calif.
63. Wira, C. R., and C. Kaushic. 1996. Mucosal immunity in the female reproductive tact: effect of sex hormones on immune recognition and responses, p. 375-388. In H. Kiyono, P. L. Ogra, and J. R. McGhee (ed.), Mucosal vaccines. Academic Press, Inc., San Diego, Calif.
64. Wira, C. R., and C. P. Sandoe. 1987. Origin of IgA and IgG antibodies in the female reproductive tract: regulation of the genital response by estradiol. Adv. Exp. Med. Biol. 216A:403-412.
65. Wu, H. Y., and M. W. Russell.1997. Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system. Immunol. Res. 16:187-201.
66. Yuan, L., L. A. Ward, B. I. Rosen, T. L. To, and L. J. Saif. 1996. Systematic and intestinal antibody-secreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease. J. Virol. 70:3075-3083.